Here are the 10-Q quarterly reports from Dalrada Fincl Corp (DFCO) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow DFCO and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full DFCO filings page.
Dalrada Technology Group reported continued losses and severe balance sheet weakness for the quarter ended December 31, 2025. Total revenue was $3.26 million, roughly flat versus the prior year’s $3.11 million, while six‑month revenue fell to $7.36 million from $9.15 million. Gross profit improved to $1.12 million in the quarter, but selling, general and administrative expenses of $4.70 million kept operations unprofitable, leading to a quarterly operating loss of $3.57 million and a six‑month net loss of $10.49 million.
The company’s financial position is strained. It ended the period with only $70,074 of cash and cash equivalents, total assets of $17.59 million, and total liabilities of $34.49 million, resulting in a stockholders’ deficit of $16.90 million. Management discloses negative working capital of $15.34 million and states there is “substantial doubt” about Dalrada’s ability to continue as a going concern without new financing and improved subsidiary performance.
Dalrada relies heavily on related‑party financing, with $8.58 million in related‑party payables and $4.64 million in related‑party notes payable, and has layered on multiple high‑cost loans and revenue purchase agreements. Operating cash outflows of $3.26 million in the first half of fiscal 2026 were covered only by $3.00 million of net cash from financing activities.
Dalrada Financial Corporation (DFCO) reported fiscal Q1 2026 results for the quarter ended September 30, 2025. Total revenue was $4,098,786, down from $6,030,655 a year ago, with product sales weaker and services making up most of the quarter. Gross profit was $560,178 and the company posted a net loss of $6,063,068, similar to the prior year’s loss.
Operating expenses were $5,879,442. Cash used in operating activities was $4,216,845, offset by $4,521,215 of financing cash inflows, largely from related party notes. As of September 30, 2025, assets totaled $17,984,117 and liabilities were $30,582,753, resulting in a stockholders’ deficit of $12,598,636. Management disclosed negative working capital of $11,660,541 and “substantial doubt” about the company’s ability to continue as a going concern, citing reliance on collections from healthcare payers, heat pump sales, and subsidiary projects.
As of November 14, 2025, common shares outstanding were 120,157,113. Related party notes payable increased to $3,723,405. Deferred revenue reached $1,910,269, and contingent consideration remained $211,289.